Subscribe
Several studies have examined the costs associated with actively educating and supporting family caregivers of people who have had a stroke, yet provide only limited evidence that such interventions are cost-effective.
A recent test-run of a mobile stroke unit (MSU) in Houston, TX, has shown preliminary success in the treatment of patients diagnosed with ischemic stroke.
Patients with treatment-resistant epilepsy may benefit from a treatment regimen that includes cannabidiol (Epidiolex), a compound in medical marijuana that does not contain psychoactive properties.
The FDA approved a single-capsule, fixed-dose combination therapy of memantine hydrochloride extended-release and donepezil hydrochloride (Namzaric; Adamas Pharmaceuticals and Actavis) for the treatment of moderate to severe dementia of the Alzheimer’s type in patients who have been stabilized with memantine hydrochloride and donepezil hydrochloride.
The FDA approved diclofenac sodium (Dyloject; Hospira) injection, a proprietary nonsteroidal anti-inflammatory drug (NSAID) analgesic, for the treatment of adult patients with mild to moderate pain, and moderate to severe pain alone or in combination with opioid analgesics.
In the year following a relapse, patients with multiple sclerosis remained less productive and their health deteriorated further compared with patients with multiple sclerosis whose disease had not relapsed, according to analyses presented at the 2015 annual meeting of the American Academy of Neurology.
Clinical and in-hospital process variables are associated with hospital length of stay (LOS) in acute ischemic stroke patients, according to data presented at the 2015 annual meeting of the American Academy of Neurology.
The costs for inpatient care are significantly affected by the age and sex of patients with multiple sclerosis (MS) who experience disease relapse, according to data presented at the 2015 annual meeting of the American Academy of Neurology.
Those looking for equality based on race and sex won’t find it in the treatment of Parkinson’s disease.
At the 2015 annual meeting of the American Academy of Neurology, experts engaged in a series of debates that touched on current and controversial issues in the field of neuroscience.
Page 2 of 3
Results 11 - 20 of 22
  • American Health & Drug Benefits
  • Lynx CME
  • Value-Based Care in Myeloma
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology